成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart 0 Sign in  

[ CAS No. 4975-73-9 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 4975-73-9
Chemical Structure| 4975-73-9
Structure of 4975-73-9 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 4975-73-9 ]

Related Doc. of [ 4975-73-9 ]

Alternatived Products of [ 4975-73-9 ]
Product Citations

Product Details of [ 4975-73-9 ]

CAS No. :4975-73-9 MDL No. :MFCD00063252
Formula : C17H31N3O Boiling Point : -
Linear Structure Formula :- InChI Key :OZNYZQOTXQSUJM-UHFFFAOYSA-N
M.W : 293.45 Pubchem ID :21079
Synonyms :

Calculated chemistry of [ 4975-73-9 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 21
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.94
Num. rotatable bonds : 4
Num. H-bond acceptors : 2.0
Num. H-bond donors : 1.0
Molar Refractivity : 91.87
TPSA : 36.86 ?2

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : Yes
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.05 cm/s

Lipophilicity

Log Po/w (iLOGP) : 3.42
Log Po/w (XLOGP3) : 2.88
Log Po/w (WLOGP) : 2.55
Log Po/w (MLOGP) : 2.72
Log Po/w (SILICOS-IT) : 2.94
Consensus Log Po/w : 2.9

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.21
Solubility : 0.181 mg/ml ; 0.000617 mol/l
Class : Soluble
Log S (Ali) : -3.31
Solubility : 0.142 mg/ml ; 0.000485 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.08
Solubility : 0.246 mg/ml ; 0.000839 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 2.0 alert
Leadlikeness : 0.0
Synthetic accessibility : 3.51

Safety of [ 4975-73-9 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 4975-73-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 4975-73-9 ]

[ 4975-73-9 ] Synthesis Path-Upstream   1~3

  • 1
  • [ 110-91-8 ]
  • [ 538-75-0 ]
  • [ 4975-73-9 ]
YieldReaction ConditionsOperation in experiment
98% at 50℃; for 2 h; Inert atmosphere General procedure: A 10 mL Schlenk tube was charged with III (0.0128 g, 0.0075 mmol), N,N'-diisopropylcarbodiimide (0.189 g, 1.5 mmol), and aniline (0.140 g, 1.5 mmol) under dried argon. The resulting mixture was stirred at 25 °C for 30 min. The reaction mixture was extracted with ether and filtered to give a clean solution. After removing the solvent under vacuum, the residue was recrystallized in ether to provide a white solid 1 in >99percent yield.
96% With zinc(II) oxide In toluene at 110℃; for 10 h; General procedure: A mixture of amine (1 mmol), carbodiimide (1.1 mmol) and nanocrystalline ZnO (20 mol percent, 0.016 g) was stirred in toluene (1 mL) at 80 °C for 8 h (for aromatic and aliphatic primary amines) or at 110 °C for 10 h (for secondary amines). The progress of the reaction was monitored by TLC analysis. At the end of the reaction, the reaction mixture was allowed to cool to room temperature, centrifuged and filtered the supernatant through a sintered funnel. The catalyst was then washed with ethyl acetate, centrifuged and filtered. The combined filtrate was concentrated under reduced pressure, and further purified by column chromatography on neutral alumina using ethyl acetate/hexane as the eluent to afford the desired product in good yields.
96% With iron(II) acetate In toluene at 140℃; for 5 h; Inert atmosphere General procedure: A Schlenk tube under nitrogen was charged with Fe(OAc)2 (8.70 mg, 0.05 mmol), the corresponding amine (1 mmol) and carbodiimide (1.2 mmol) and toluene (2 mL). The resulting suspension was heated at 140 oC and the progress of the reaction was monitored by TLC. At the end of the reaction, the reaction mixture was allowed to cool to room temperature and then hydrolyzed with water (5 mL), extracted with dichloromethane (3 10 mL), dried over anhydrous Na2SO4 and filtered. Then, the solvent was evaporated under reduced pressure to give the crude product which was purified by recrystallization method in hexane or diethyl ether and also by column chromatography to afford the desired products in good yields.
96% With 1,3-di-tert-butylimidazol-2-ylidene:Mg[N(SiMe3)2]2 In toluene at 110℃; for 24 h; Schlenk technique; Inert atmosphere; Glovebox General procedure: A 30 mL Schlenk tube under inert atmosphere (N2-glovebox) was charged with the catalyst ItBu:Mg[N(SiMe3)2]2 (0.03 equiv), secondary amine (1.0 equiv), and toluene (5 mL). To this mixture carbodiimides (1.0 equiv) was added. The flask was then closed to prevent evaporation of amines with low boiling points, and the resulting mixture was heated to 110 °C for the desired time. The solvent was removed under reduced pressure; the residue was extracted with hexane (3 x 15 mL) and filtered to give a clean solution. After removing the hexane under reduced pressure, the final products were obtained.

Reference: [1] Journal of Organic Chemistry, 2008, vol. 73, # 22, p. 8966 - 8972
[2] Tetrahedron, 2011, vol. 67, # 45, p. 8790 - 8799
[3] Tetrahedron, 2012, vol. 68, # 29, p. 5730 - 5737
[4] Tetrahedron Letters, 2012, vol. 53, # 38, p. 5156 - 5158
[5] Journal of Organometallic Chemistry, 2014, vol. 769, p. 112 - 118
[6] Journal of Organic Chemistry, 2009, vol. 74, # 16, p. 6347 - 6349
[7] Journal of Organometallic Chemistry, 2012, vol. 713, p. 27 - 34
[8] Collection of Czechoslovak Chemical Communications, 2006, vol. 71, # 8, p. 1211 - 1220
  • 2
  • [ 108-91-8 ]
  • [ 4975-73-9 ]
Reference: [1] Journal of Medicinal Chemistry, 1994, vol. 37, # 22, p. 3693 - 3700
  • 3
  • [ 36903-85-2 ]
  • [ 4975-73-9 ]
Reference: [1] Journal of Medicinal Chemistry, 1994, vol. 37, # 22, p. 3693 - 3700
Recommend Products
Same Skeleton Products

Technical Information

Historical Records

Related Functional Groups of
[ 4975-73-9 ]

Amines

Chemical Structure| 412356-24-2

[ 412356-24-2 ]

trans-4-Morpholinocyclohexanamine dihydrochloride

Similarity: 0.60

Chemical Structure| 82451-48-7

[ 82451-48-7 ]

N1,N6-Bis(2,2,6,6-tetramethylpiperidin-4-yl)hexane-1,6-diamine 4-(4,6-dichloro-1,3,5-triazin-2-yl)morpholine(Poly)

Similarity: 0.60

Chemical Structure| 29166-72-1

[ 29166-72-1 ]

2-(tert-Butyl)-1,1,3,3-tetramethylguanidine

Similarity: 0.51

Chemical Structure| 26893-39-0

[ 26893-39-0 ]

2-Amino-1,4,5,6-tetrahydropyrimidine Hydrochloride

Similarity: 0.50

Related Parent Nucleus of
[ 4975-73-9 ]

Aliphatic Heterocycles

Chemical Structure| 412356-24-2

[ 412356-24-2 ]

trans-4-Morpholinocyclohexanamine dihydrochloride

Similarity: 0.60

Chemical Structure| 5807-14-7

[ 5807-14-7 ]

2,3,4,6,7,8-Hexahydro-1H-pyrimido[1,2-a]pyrimidine

Similarity: 0.60

Chemical Structure| 1228947-14-5

[ 1228947-14-5 ]

trans-4-Morpholinocyclohexanol

Similarity: 0.58

Chemical Structure| 53617-35-9

[ 53617-35-9 ]

4-Morpholinopiperidine

Similarity: 0.57

Chemical Structure| 1588441-09-1

[ 1588441-09-1 ]

trans-4-Morpholinocyclohexanol hydrochloride

Similarity: 0.57

Morpholines

Chemical Structure| 412356-24-2

[ 412356-24-2 ]

trans-4-Morpholinocyclohexanamine dihydrochloride

Similarity: 0.60

Chemical Structure| 82451-48-7

[ 82451-48-7 ]

N1,N6-Bis(2,2,6,6-tetramethylpiperidin-4-yl)hexane-1,6-diamine 4-(4,6-dichloro-1,3,5-triazin-2-yl)morpholine(Poly)

Similarity: 0.60

Chemical Structure| 1228947-14-5

[ 1228947-14-5 ]

trans-4-Morpholinocyclohexanol

Similarity: 0.58

Chemical Structure| 53617-35-9

[ 53617-35-9 ]

4-Morpholinopiperidine

Similarity: 0.57

Chemical Structure| 1588441-09-1

[ 1588441-09-1 ]

trans-4-Morpholinocyclohexanol hydrochloride

Similarity: 0.57

Guanidines

Chemical Structure| 29166-72-1

[ 29166-72-1 ]

2-(tert-Butyl)-1,1,3,3-tetramethylguanidine

Similarity: 0.51

; ;